Please login to the form below

Not currently logged in
Email:
Password:

P/LAIV

This page shows the latest P/LAIV news and features for those working in and with pharma, biotech and healthcare.

GSK gene therapy tops CHMP recommendations

GSK gene therapy tops CHMP recommendations

P/LAIV is intended for the prevention of influenza in an officially declared pandemic in children and adolescents from 12 months to less than 18 years of age.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics